EFFICACY OF CYCLOSPORINE EYE DROPS IN TREATMENT OF MEIBOMIAN GLAND DISEASE

ABSTRACT Objective: To assess the efficacy of topical cyclosporine ophthalmic solution in patients with Meibomian Gland Disease. Study Design: Quasi-experimental study. Place and Duration of Study: Armed Forces Institute of Ophthalmology(AFIO), from March to May 2019. Methodology: Adult patients of...

Full description

Saved in:
Bibliographic Details
Published in:Pakistan Armed Forces medical journal 2020-08, Vol._ (4), p.1164
Main Authors: Khan, Fatima, Khan, Summaya, Akram, Amjad, Basit, Imran, Humayun, Sadia, Rabbani, Shafaq
Format: Article
Language:English
Subjects:
Age
Disease
Females
Inflammation
Lubricants & lubrication
Males
Patients
Polyvinyl alcohol
Standard deviation
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 4
container_start_page 1164
container_title Pakistan Armed Forces medical journal
container_volume _
creator Khan, Fatima
Khan, Summaya
Akram, Amjad
Basit, Imran
Humayun, Sadia
Rabbani, Shafaq
description ABSTRACT Objective: To assess the efficacy of topical cyclosporine ophthalmic solution in patients with Meibomian Gland Disease. Study Design: Quasi-experimental study. Place and Duration of Study: Armed Forces Institute of Ophthalmology(AFIO), from March to May 2019. Methodology: Adult patients of 20-40 years of age, diagnosed for Meibomian Gland Dysfunction, were enrolled and divided into two groups(group A was assigned cyclosporine and group B was assigned polyvinyl alcohol povidone eye solution). Patients were instructed to administer one drop of the assigned treatment in each eye, twice daily, for 3-months. Two follow-up visits were planned for this study, first follow-up was conducted after thirty days of starting the assigned treatment while second follow-up was done at the end of three months. Results: There were total 80 patients enrolled, forty in each group. Patients were assessed for ocular signs and symptoms for Meibomian Gland Disease after one, two and three months of starting the treatment and were compared to control group. Patients belonging to cyclosporine group were found to show greater improvements in signs/symptoms of Meibomian Gland Disease including tear break up time(p 0.001 vs 0.540), Schrimer I test(p 0.001 vs 0.290), fluoresceine staining(0.007 vs 0.041), lid margin/conjunctival inflammation(0.001 vs 0.06) and Meibomian Gland expressibility(0.01 vs 0.311). Conclusion: Topical cyclosporine ophthalmic solution was found to be significantly better in resolving ocular signs and symptoms among Meibomian Gland Disease patients as compared to polyvinyl alcohol povidone.
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2446563363</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2446563363</sourcerecordid><originalsourceid>FETCH-proquest_journals_24465633633</originalsourceid><addsrcrecordid>eNqNikELgjAYhkcUJOV_GHQWlptixzW_1UI3cbt4kg52kMhy-f8z6Af08MJzeJ8FCmK230dZxuIlCgihJDqkLFuj0PuezCQ0ZiQJ0AWkVIKLBhuJRSMKYytTKw0YGsB5bSqLlcauBu5K0O6blaCOplRc41PBdY5zZYFb2KLV7Xr3XfjzBu0kOHGOnuPwmjr_bvthGh_z1caMpUlK6bz_qg9XAjbe</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2446563363</pqid></control><display><type>article</type><title>EFFICACY OF CYCLOSPORINE EYE DROPS IN TREATMENT OF MEIBOMIAN GLAND DISEASE</title><source>Nexis UK</source><source>Publicly Available Content Database</source><creator>Khan, Fatima ; Khan, Summaya ; Akram, Amjad ; Basit, Imran ; Humayun, Sadia ; Rabbani, Shafaq</creator><creatorcontrib>Khan, Fatima ; Khan, Summaya ; Akram, Amjad ; Basit, Imran ; Humayun, Sadia ; Rabbani, Shafaq</creatorcontrib><description>ABSTRACT Objective: To assess the efficacy of topical cyclosporine ophthalmic solution in patients with Meibomian Gland Disease. Study Design: Quasi-experimental study. Place and Duration of Study: Armed Forces Institute of Ophthalmology(AFIO), from March to May 2019. Methodology: Adult patients of 20-40 years of age, diagnosed for Meibomian Gland Dysfunction, were enrolled and divided into two groups(group A was assigned cyclosporine and group B was assigned polyvinyl alcohol povidone eye solution). Patients were instructed to administer one drop of the assigned treatment in each eye, twice daily, for 3-months. Two follow-up visits were planned for this study, first follow-up was conducted after thirty days of starting the assigned treatment while second follow-up was done at the end of three months. Results: There were total 80 patients enrolled, forty in each group. Patients were assessed for ocular signs and symptoms for Meibomian Gland Disease after one, two and three months of starting the treatment and were compared to control group. Patients belonging to cyclosporine group were found to show greater improvements in signs/symptoms of Meibomian Gland Disease including tear break up time(p 0.001 vs 0.540), Schrimer I test(p 0.001 vs 0.290), fluoresceine staining(0.007 vs 0.041), lid margin/conjunctival inflammation(0.001 vs 0.06) and Meibomian Gland expressibility(0.01 vs 0.311). Conclusion: Topical cyclosporine ophthalmic solution was found to be significantly better in resolving ocular signs and symptoms among Meibomian Gland Disease patients as compared to polyvinyl alcohol povidone.</description><identifier>ISSN: 0030-9648</identifier><identifier>EISSN: 2411-8842</identifier><language>eng</language><publisher>Rawalpindi: AsiaNet Pakistan (Pvt) Ltd</publisher><subject>Age ; Disease ; Females ; Inflammation ; Lubricants &amp; lubrication ; Males ; Patients ; Polyvinyl alcohol ; Standard deviation</subject><ispartof>Pakistan Armed Forces medical journal, 2020-08, Vol._ (4), p.1164</ispartof><rights>(c)2020 Pakistan Armed Forces Medical Journal</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2446563363/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2446563363?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25753,37012,44590,75126</link.rule.ids></links><search><creatorcontrib>Khan, Fatima</creatorcontrib><creatorcontrib>Khan, Summaya</creatorcontrib><creatorcontrib>Akram, Amjad</creatorcontrib><creatorcontrib>Basit, Imran</creatorcontrib><creatorcontrib>Humayun, Sadia</creatorcontrib><creatorcontrib>Rabbani, Shafaq</creatorcontrib><title>EFFICACY OF CYCLOSPORINE EYE DROPS IN TREATMENT OF MEIBOMIAN GLAND DISEASE</title><title>Pakistan Armed Forces medical journal</title><description>ABSTRACT Objective: To assess the efficacy of topical cyclosporine ophthalmic solution in patients with Meibomian Gland Disease. Study Design: Quasi-experimental study. Place and Duration of Study: Armed Forces Institute of Ophthalmology(AFIO), from March to May 2019. Methodology: Adult patients of 20-40 years of age, diagnosed for Meibomian Gland Dysfunction, were enrolled and divided into two groups(group A was assigned cyclosporine and group B was assigned polyvinyl alcohol povidone eye solution). Patients were instructed to administer one drop of the assigned treatment in each eye, twice daily, for 3-months. Two follow-up visits were planned for this study, first follow-up was conducted after thirty days of starting the assigned treatment while second follow-up was done at the end of three months. Results: There were total 80 patients enrolled, forty in each group. Patients were assessed for ocular signs and symptoms for Meibomian Gland Disease after one, two and three months of starting the treatment and were compared to control group. Patients belonging to cyclosporine group were found to show greater improvements in signs/symptoms of Meibomian Gland Disease including tear break up time(p 0.001 vs 0.540), Schrimer I test(p 0.001 vs 0.290), fluoresceine staining(0.007 vs 0.041), lid margin/conjunctival inflammation(0.001 vs 0.06) and Meibomian Gland expressibility(0.01 vs 0.311). Conclusion: Topical cyclosporine ophthalmic solution was found to be significantly better in resolving ocular signs and symptoms among Meibomian Gland Disease patients as compared to polyvinyl alcohol povidone.</description><subject>Age</subject><subject>Disease</subject><subject>Females</subject><subject>Inflammation</subject><subject>Lubricants &amp; lubrication</subject><subject>Males</subject><subject>Patients</subject><subject>Polyvinyl alcohol</subject><subject>Standard deviation</subject><issn>0030-9648</issn><issn>2411-8842</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqNikELgjAYhkcUJOV_GHQWlptixzW_1UI3cbt4kg52kMhy-f8z6Af08MJzeJ8FCmK230dZxuIlCgihJDqkLFuj0PuezCQ0ZiQJ0AWkVIKLBhuJRSMKYytTKw0YGsB5bSqLlcauBu5K0O6blaCOplRc41PBdY5zZYFb2KLV7Xr3XfjzBu0kOHGOnuPwmjr_bvthGh_z1caMpUlK6bz_qg9XAjbe</recordid><startdate>20200831</startdate><enddate>20200831</enddate><creator>Khan, Fatima</creator><creator>Khan, Summaya</creator><creator>Akram, Amjad</creator><creator>Basit, Imran</creator><creator>Humayun, Sadia</creator><creator>Rabbani, Shafaq</creator><general>AsiaNet Pakistan (Pvt) Ltd</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20200831</creationdate><title>EFFICACY OF CYCLOSPORINE EYE DROPS IN TREATMENT OF MEIBOMIAN GLAND DISEASE</title><author>Khan, Fatima ; Khan, Summaya ; Akram, Amjad ; Basit, Imran ; Humayun, Sadia ; Rabbani, Shafaq</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_24465633633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Age</topic><topic>Disease</topic><topic>Females</topic><topic>Inflammation</topic><topic>Lubricants &amp; lubrication</topic><topic>Males</topic><topic>Patients</topic><topic>Polyvinyl alcohol</topic><topic>Standard deviation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Khan, Fatima</creatorcontrib><creatorcontrib>Khan, Summaya</creatorcontrib><creatorcontrib>Akram, Amjad</creatorcontrib><creatorcontrib>Basit, Imran</creatorcontrib><creatorcontrib>Humayun, Sadia</creatorcontrib><creatorcontrib>Rabbani, Shafaq</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Pakistan Armed Forces medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khan, Fatima</au><au>Khan, Summaya</au><au>Akram, Amjad</au><au>Basit, Imran</au><au>Humayun, Sadia</au><au>Rabbani, Shafaq</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>EFFICACY OF CYCLOSPORINE EYE DROPS IN TREATMENT OF MEIBOMIAN GLAND DISEASE</atitle><jtitle>Pakistan Armed Forces medical journal</jtitle><date>2020-08-31</date><risdate>2020</risdate><volume>_</volume><issue>4</issue><spage>1164</spage><pages>1164-</pages><issn>0030-9648</issn><eissn>2411-8842</eissn><abstract>ABSTRACT Objective: To assess the efficacy of topical cyclosporine ophthalmic solution in patients with Meibomian Gland Disease. Study Design: Quasi-experimental study. Place and Duration of Study: Armed Forces Institute of Ophthalmology(AFIO), from March to May 2019. Methodology: Adult patients of 20-40 years of age, diagnosed for Meibomian Gland Dysfunction, were enrolled and divided into two groups(group A was assigned cyclosporine and group B was assigned polyvinyl alcohol povidone eye solution). Patients were instructed to administer one drop of the assigned treatment in each eye, twice daily, for 3-months. Two follow-up visits were planned for this study, first follow-up was conducted after thirty days of starting the assigned treatment while second follow-up was done at the end of three months. Results: There were total 80 patients enrolled, forty in each group. Patients were assessed for ocular signs and symptoms for Meibomian Gland Disease after one, two and three months of starting the treatment and were compared to control group. Patients belonging to cyclosporine group were found to show greater improvements in signs/symptoms of Meibomian Gland Disease including tear break up time(p 0.001 vs 0.540), Schrimer I test(p 0.001 vs 0.290), fluoresceine staining(0.007 vs 0.041), lid margin/conjunctival inflammation(0.001 vs 0.06) and Meibomian Gland expressibility(0.01 vs 0.311). Conclusion: Topical cyclosporine ophthalmic solution was found to be significantly better in resolving ocular signs and symptoms among Meibomian Gland Disease patients as compared to polyvinyl alcohol povidone.</abstract><cop>Rawalpindi</cop><pub>AsiaNet Pakistan (Pvt) Ltd</pub><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0030-9648
ispartof Pakistan Armed Forces medical journal, 2020-08, Vol._ (4), p.1164
issn 0030-9648
2411-8842
language eng
recordid cdi_proquest_journals_2446563363
source Nexis UK; Publicly Available Content Database
subjects Age
Disease
Females
Inflammation
Lubricants & lubrication
Males
Patients
Polyvinyl alcohol
Standard deviation
title EFFICACY OF CYCLOSPORINE EYE DROPS IN TREATMENT OF MEIBOMIAN GLAND DISEASE
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T20%3A01%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=EFFICACY%20OF%20CYCLOSPORINE%20EYE%20DROPS%20IN%20TREATMENT%20OF%20MEIBOMIAN%20GLAND%20DISEASE&rft.jtitle=Pakistan%20Armed%20Forces%20medical%20journal&rft.au=Khan,%20Fatima&rft.date=2020-08-31&rft.volume=_&rft.issue=4&rft.spage=1164&rft.pages=1164-&rft.issn=0030-9648&rft.eissn=2411-8842&rft_id=info:doi/&rft_dat=%3Cproquest%3E2446563363%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_journals_24465633633%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2446563363&rft_id=info:pmid/&rfr_iscdi=true